SGLT2 Inhibitors, What the Emergency Physician Needs to Know: A Narrative Review

Canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin belong to a class of antidiabetic treatments referred to as sodium-glucose cotransporter 2 inhibitors (SGLT2 inhibitors, or SGLT2is). SGLT2is are currently indicated in North America and in Europe in type 2 diabetes mellitus, especially...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Henri, Lu, Hortense, Kosinski, Christophe, Wojtusciszyn, Anne, Zanchi, Anne, Carron, Pierre-Nicolas, Müller, Martin, Meyer, Philippe, Martin, Jehan, Muller, Olivier, Hullin, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126052/
https://www.ncbi.nlm.nih.gov/pubmed/34068655
http://dx.doi.org/10.3390/jcm10092036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126052/
https://www.ncbi.nlm.nih.gov/pubmed/34068655
http://dx.doi.org/10.3390/jcm10092036

Ejemplares similares